Албиомин

Албиомин is a sterile, ready-to-use solution of Human Serum Albumin for intravenous use, sourced from EU-manufactured plasma. It supports plasma volume expansion and protein replacement in clinical settings. A key option for albumin therapy, it is designed for broad compatibility in medical care. Suitable for patients requiring protein supplementation or volume support.

Албиомин is used to restore and maintain blood volume when it has been reduced due to surgery, injury, or other conditions. It helps manage protein deficiency and supports fluid balance in the body. This solution is commonly used in hospitals and clinical environments where albumin levels need correction. It is not intended for general wellness or self-administration.

As a protein-based solution, Албиомин works by increasing plasma oncotic pressure to help retain fluid within the blood vessels. Patients may experience improved circulatory stability and reduced edema in affected areas. The effects are typically observed shortly after administration and depend on individual clinical needs. It is designed to support, not replace, normal physiological processes.

Handle Албиомин with care as it is intended for intravenous use only by trained medical professionals. Ensure proper storage conditions and inspect the solution for clarity and particulate matter before administration. Patients with known allergies to human blood products should use this product cautiously. Always follow clinical protocols for infusion rates and monitoring.

No specific drug interactions are widely documented for Албиомин, but caution is advised when used with medications affecting blood pressure or fluid balance. Concurrent use with diuretics or ACE inhibitors may require careful monitoring. As a protein solution, it is generally compatible with other intravenous therapies. Always consult medical guidance before combining with other treatments.